QIAGEN N.V. (QIA.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002SN0 - Common Stock
QIA.DE Key Statistics, Chart & Performance
The current stock price of QIA.DE is 44.715 EUR. In the past month the price increased by 9.61%. In the past year, price decreased by -0.97%.
QIA.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to QIA.DE. When comparing the yearly performance of all stocks, QIA.DE turns out to be only a medium performer in the overall market: it outperformed 45.71% of all stocks.
QIA.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE. QIA.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
QIA.DE Financial Highlights
Over the last trailing twelve months QIA.DE reported a non-GAAP Earnings per Share(EPS) of 2.06. The EPS increased by 12.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.58% | ||
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| Debt/Equity | 0.45 |
QIA.DE Forecast & Estimates
24 analysts have analysed QIA.DE and the average price target is 46.93 EUR. This implies a price increase of 4.95% is expected in the next year compared to the current price of 44.715.
For the next year, analysts expect an EPS growth of 13.29% and a revenue growth 5% for QIA.DE
QIA.DE Ownership
About QIA.DE
Company Profile
Qiagen NV is a NL-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Venlo, Limburg and currently employs 5,700 full-time employees. Qiagen NV is a holding company based in the Netherlands. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Company Info
QIAGEN N.V.
Hulsterweg 82
Venlo LIMBURG NL
Employees: 5232
Phone: 31773556600
QIAGEN N.V. / QIA.DE FAQ
What does QIA do?
Qiagen NV is a NL-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Venlo, Limburg and currently employs 5,700 full-time employees. Qiagen NV is a holding company based in the Netherlands. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Can you provide the latest stock price for QIAGEN N.V.?
The current stock price of QIA.DE is 44.715 EUR. The price decreased by -1.69% in the last trading session.
Does QIAGEN N.V. pay dividends?
QIAGEN N.V. (QIA.DE) has a dividend yield of 0.49%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of QIA stock?
QIA.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is QIAGEN N.V. (QIA.DE) stock traded?
QIA.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is QIAGEN N.V. worth?
QIAGEN N.V. (QIA.DE) has a market capitalization of 9.70B EUR. This makes QIA.DE a Mid Cap stock.